RBC Capital Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from Sector Perform to Outperform with a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
